Menu Menu

CHRS    Coherus Biosciences Inc    1512762    
Income Statement
Revenue 70,774,000
Net Income -10,751,000
Profit Margin -15.19%

Balance Sheet
Current Assets 369,024,000
Assets 505,000,000
Current Liabilities 295,566,000
Liabilities 592,973,000
Equity -87,973,000
Shares Out 115,209,000

Cash Flow Statement
Operating Cash Flow -49,048,000
Investing Cash Flow 230,863,000

Market Analysis
Market Cap 122,132,632
Price 1.39
BVPS 6.25
PB 0.22
EPS -0.40
PS 0.43
FCF 181,815,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
3/13
Apr May Jun
5/09 -0.32
Jul Aug Sep
8/08 -0.14
Oct Nov Dec
11/11

Find a discrepancy? The most accurate way to find company fundamental data is to view CHRS documents filed with the SEC.


CHRS Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: